Cole Eye Institute - Cleveland Clinic

More documents

Recommendations

Info

Postoperative eyelid symmetry results were excellent in approximately 96.6 percent of cases and good in the remaining 3.4 percent of cases. Excellent and good eyelid symmetry were defined as a marginal reflex distance (MRD) within 0.5 mm and 1.0 mm of the desired position, respectively. Postoperative Eyelid Symmetry N = 564 3.4% Good 96.6% Excellent Postoperative Complications of Lacrimal Surgery N = 49 4.1% Need Revision 4.1% Need Reoperation 2.0% Other Other, 2.0% N = 49 Lacrimal surgery outcome measures included intraoperative complications None, 89.8% and reoperation rate. A total of 145 lacrimal surgeries were performed from January 2006 through September 2007. There were no intraoperative complications and the reoperation rate was 4.1 percent. Orbital surgery outcome measures included intraoperative complications and reoperation rate. At the Cole Eye Institute, 83 orbital surgeries were performed from January 2006 through September 2007. There were no intraoperative complications, and no patient required reoperation or revision. 89.8% None Outcomes 2007 16
Ocular Oncology Surgery A melanoma is a primary tumor of the skin or eye. In the eye, it arises from the pigmented cells of the uvea (choroid, ciliary body or iris). Uveal melanoma of the eye occurs in 4.3 people per million population per year. It almost always occurs in one eye and is more common in fair-skinned, blue-eyed people. In the past, enucleation was the only treatment for uveal melanoma. In recent years, new methods of treatment have been developed that may be used to save the eye. At Cole Eye Institute, we have increasingly used radioactive plaque for the treatment of uveal melanoma. From July 2006 through December 2007, we have treated 71 new patients with uveal melanoma, with the majority (89 percent) undergoing plaque radiotherapy. Treatment of Uveal Melanoma N = 71 Treatment of Recurrent 11% Uveal Enucleation Melanoma Plaques containing iodine-125 and ruthenium-106 are used at Cole Eye Institute on a regular basis. If tumors are < 5 mm in height, the ruthenium-106 plaque is preferred. The size of the plaque is determined by the diameter of the tumor. Over the short term, we have observed initial tumor regression with preservation of vision in almost all cases. However, five patients (6 percent) had tumors recur, requiring additional treatment with plaque or enucleation. Treatment of Recurrent Uveal Melanoma N = 5 40% Plaque Radiotherapy 89% Plaque Radiotherapy 60% Enucleation 17 Cole Eye Institute
Page 1 and 2: 1 Cole Eye Institute Outcomes | 200
Page 3 and 4: 1 Outcomes 2007 Quality counts when
Page 5 and 6: what’s inside Chairman’s Letter
Page 7 and 8: Institute Overview At Cleveland Cli
Page 9 and 10: Cataract Surgery 7 Complications du
Page 11 and 12: Cornea Surgery Corneal transplant s
Page 13 and 14: Postoperative Complications 80 60 4
Page 15 and 16: Change in Intraocular Pressure Intr
Page 17: Oculoplastic Surgery Oculoplastic s
Page 21 and 22: Refractive Surgery 100 Outcomes 80
Page 23 and 24: Vitreoretinal Surgery 60 50 The vit
Page 25 and 26: An analysis of intraoperative compl
Page 27 and 28: Surgical Outcome for Adults N=151 1
Page 29 and 30: Innovations Retinopathy of Prematur
Page 31 and 32: Advanced Corneal Imaging Sheds Ligh
Page 33 and 34: Jeng BH, Holland GN, Lowder CY, Dee
Page 35 and 36: Book Chapters Bollinger K, Smith SD
Page 37 and 38: Uveitis Careen Y. Lowder, MD, PhD O
Page 39 and 40: Cleveland Clinic Overview Online Se

Cole Eye Institute - Cleveland Clinic

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?